Area of research
Endocrinology, Diabetes and Metabolism · Molecular Biology
Research interest
Research interests include Diabetes Management and Research, Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events
Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
Consensus report: definition and interpretation of remission in type 2 diabetes
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial
Red and Processed Meats and Health Risks: How Strong Is the Evidence?
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a <i>Diabetes Care</i> Editors’ Expert Forum
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Big Topics for <i>Diabetes Care</i> in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a<i>Diabetes Care</i>Editors’ Expert Forum
Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide
Diabetes Research and Care Through the Ages
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia
Beyond Metformin: Safety Considerations in the Decision-Making Process for Selecting a Second Medication for Type 2 Diabetes Management
Personalized Management of Hyperglycemia in Type 2 Diabetes
Contributions of Basal and Prandial Hyperglycemia to Total Hyperglycemia in Older and Younger Adults with Type 2 Diabetes Mellitus
Risk of Breast Cancer by Individual Insulin Use: An International Multicenter Study